Joanne van Ryn - Concepedia

Author

Joanne van Ryn

Also Known As

J Van Ryn, J. VAN RYN, J. VAN Ryn, J. Van Ryn, J. van RYN, J. van Ryn, Joachim Stangier, Joanne Van Ryn, Joanne van Ryn, Martin Lorenz

152

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Boehringer Ingelheim (United States)RWTH Aachen University McMaster University Heidelberg University

About

Joanne van Ryn is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	2K
2	Health Sciences	4	4	136
3	Biochemistry	2	2	170
4	Natural Sciences	1	1	92
5	Public Health	1	1	20

Joanne van Ryn

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis Charles V. Pollack, Paul Reilly, Joanne van Ryn, New England Journal of Medicine	2017	1.1K
A specific antidote for dabigatran: functional and structural characterization Felix Schiele, Joanne van Ryn, Keith A. Canada, Blood	2013	560
Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran Wei Zhou, Sönke Schwarting, Sergio Illanes, Stroke	2011	326
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial Stephan Glund, Joachim Stangier, Michael Schmohl, The Lancet ThrombosisVenous ThrombosisCardiovascular DiseaseAnticoagulant EffectHealthy Male Volunteers	2015	317
A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran Viktoria Moschetti, Stephen H. Norris, Joachim Stangier, Thrombosis and Haemostasis Drug SafetyTranslational MedicineMonoclonal Antibody FragmentIdarucizumab DoseHealthy Volunteers	2015	244
Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model Ingo Pragst, Stefanie Zeitler, Baerbel Doerr, Journal of Thrombosis and Haemostasis Dabigatran AnticoagulationThrombosisBeriplex P/nBlood PlateletHematology	2012	184
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect F. Fernandez, Philip V. Nguyen, Joanne van Ryn, Thrombosis Research Other GlycosaminoglycansThrombosisThrombopoiesisPlatelet DefectBlood Platelet	1986	140
Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner Julian Ilcheff Borissoff, Jeroen J. T. Otten, Sylvia Heeneman, PLoS ONE	2013	123
Thrombin promotes diet-induced obesity through fibrin-driven inflammation Anna K. Kopec, Sara R. Abrahams, Sherry Thornton, Journal of Clinical Investigation	2017	115
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease Erica Sparkenbaugh, Pichika Chantrathammachart, Jacqueline Mickelson, Blood	2014	107

Page 1